-
Venues Remedies Q2 FY26 Results
Source: Nine One Capital Published on 2025-11-10
-
When One Fraud Raised Questions on 15 Other Listed Companies
Source: Nine One Capital Published on 2025-11-08
-
Rare Earths: Positioning Early for the Next Strategic Mining Wave
Source: Nine One Capital Published on 2025-10-26
-
Eimco Elecon: A Clean Slate with Optionality Ahead
Source: Nine One Capital Published on 2025-10-14
-
How to Analyse a 100 PE Stock
Source: Nine One Capital Published on 2025-09-24
-
AI Can Read, It Can’t Infer
Source: Nine One Capital Published on 2025-09-17
-
Preparing, Not Predicting
Source: Nine One Capital Published on 2025-09-02
-
Supreme Court’s Stray Dog Ruling: A ₹20 Billion Tailwind for Animal Health Stocks?
Source: Nine One Capital Published on 2025-08-25
-
What the Indices Don’t Tell You
Source: Nine One Capital Published on 2025-08-15
-
Cooling Off to Heat Up: Why We’re Studying the AC Sector Now
Source: Nine One Capital Published on 2025-08-10
-
Unlisted Doesn’t Mean Uncertain: Our Playbook for Investing in Unlisted Companies
Source: Nine One Capital Published on 2025-08-05
-
RPTs, Governance, and a Path to Rerating
Source: Nine One Capital Published on 2025-07-31
-
Venus Remedies Annual Reports Analysis
Source: Nine One Capital Published on 2025-07-26
-
Misunderstood & Mispriced. Investing in IT Products Company
Source: Nine One Capital Published on 2025-07-24
-
E2E Networks: Reality Bites
Source: Nine One Capital Published on 2025-07-22
